Full Papers
Ultrasound versus clinical remission in patients with early rheumatoid arthritis: concordance and relationship with therapy discontinuation
R. La Ferrara1, F.G. Lazzaro2, G. Alonzi3, S. Fiore4, G. Peluso5, A.L. Fedele6, M.A. D'agostino7, A. Ortolan8
- UOC di Reumatologia, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, and Università Cattolica del Sacro Cuore, Rome, Italy.
- UOC di Reumatologia, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, and Università Cattolica del Sacro Cuore, Rome, Italy.
- UOC di Reumatologia, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, and Università Cattolica del Sacro Cuore, Rome, Italy.
- UOC di Reumatologia, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, and Università Cattolica del Sacro Cuore, Rome, Italy.
- UOC di Reumatologia, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
- UOC di Reumatologia, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
- UOC di Reumatologia, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, and Università Cattolica del Sacro Cuore, Rome, Italy.
- UOC di Reumatologia, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy. augusta.ortolan@yahoo.it
CER17290
2024 Vol.42, N°11
PI 2159, PF 2166
Full Papers
PMID: 39436716 [PubMed]
Received: 12/11/2023
Accepted : 17/04/2024
In Press: 15/10/2024
Published: 04/11/2024
Abstract
OBJECTIVES:
To evaluate prevalence of ultrasonographic remission (USR) and concordance with clinical remission in “drug-free” or “on-treatment” patients with early rheumatoid arthritis (RA).
METHODS:
We carried out a cross-sectional study including consecutive early RA patients in SDAI remission ≥6 months in the period 06/2022 to 02/2023. CDAI, DAS28, DAS44 and Boolean remission were also evaluated. Patients underwent B-mode and Power Doppler (PD) assessments of 42 joints and 20 tendons. Synovitis, tenosynovitis and PD were graded semi-quantitatively (0–3) using standardised scores. Four definitions of USR were examined: USR1: absence of synovial hypertrophy (SH) and PD; USR2: SH≤1 and PD=0; USR3: SH≤1 and PD≤1; USR4: PD negative.
RESULTS:
Eighty patients were enrolled, of whom 12 drug-free. Overall remission rates were 100.0%, 83.7%, 91.2%, 96.2% and 80.0% for SDAI, CDIA, DAS28, DAS44 and ACR/EULAR Boolean criteria, respectively. 100% of drug-free patients were in remission according to all indices. The rate of USR in drug-free versus on-treatment remission was 58.3%, 66.7%, 66.7%, 83.3% versus 70.6%, 85.3%, 88.2%, 91.2% for USR1, USR2, USR3 and USR4, respectively.
CONCLUSIONS:
While clinical remission seems more frequent in drug-free patients, USR is more often observed on-treatment.